Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.7000 (3.23%) ($14.7000 - $14.7000) on Fri. Jan. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.13% (three month average) | RSI | 45 | Latest Price | $14.7000(3.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1% a day on average for past five trading days. | Weekly Trend | ATRA declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(51%) IBB(48%) ARKG(47%) ARKK(47%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.065% in a week (0% probabilities). VIXM(-42%) VXX(-31%) UNG(-18%) USO(-14%) UUP(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.065% (StdDev 4.13%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $5.03(-65.78%) | Resistance Level | $15.2 | 5 Day Moving Average | $14.8(-0.68%) | 10 Day Moving Average | $14.83(-0.88%) | 20 Day Moving Average | $15.2(-3.29%) | To recent high | -26.1% | To recent low | 5.1% | Market Cap | $1.092b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |